Tag: FDA
BREAKING: US FDA Sets PDUFA for Roflumilast Cream 0.05% in Infants With AD – The Dermatology Digest
eczemarelief
July 8, 2026
US FDA Approves Less Frequent Lebrikizumab Dosing in AD – The Dermatology Digest
eczemarelief
June 10, 2026
FDA Accepts sNDA for Delgocitinib Cream to Treat Pediatric Chronic Hand Eczema – Dermatology Times
eczemarelief
April 15, 2026
Dermatology Drug News in Review: Key FDA Updates From 2025 – Dermatology Advisor
eczemarelief
January 9, 2026